Form D · Biotechnology
PRESSURE BIOSCIENCES INC
South Easton, MA · CIK 0000830656
Offering snapshot reported Mar 20, 2019 · SEC filing
- Reported sold
- $17.5M Indefinite offering
- Investors reported
- 43 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 2, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 20, 2019 | Initial | $17,459,551 | No comparison | 43 | SEC filing |
| Jan 27, 2016 | Initial | $5,010,000 | No comparison | 22 | SEC filing |
| Feb 21, 2013 | Initial | $1,702,800 | No comparison | 17 | SEC filing |
| Feb 21, 2012 | Initial | $800,000 | No comparison | 7 | SEC filing |
| Apr 21, 2011 | Initial | $825,720 | No comparison | 10 | SEC filing |
| Apr 13, 2010 | Initial | $19,800 | No comparison | 2 | SEC filing |
| Apr 1, 2010 | Amendment | $1,667,766 | $501,433vs Dec 3, 2009 | 31 | SEC filing |
| Dec 3, 2009 | Initial | $1,166,333 | No comparison | 20 | SEC filing |
| Feb 24, 2009 | Initial | $1,805,270 | No comparison | Not reported | SEC filing |
| Dec 7, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $416K
- Finders' fees
- $0
- Form D file number
- 021-335342
From May 2, 2018 through March 6, 2019, the Company sold the securities detailed in Item 9 for a total purchase price of $4,288,000. During the same period, the company converted debt equal to $13,171,551 into the securities detailed in Item 9.
Warrants for 318,680 shares with an exercise price of $3.50 per share were issued to Garden State as compensation in addition to their sales commissions.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None | Garden State Securities, Inc. · CRD 10083 |
Source: Form D, filed Mar 20, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph L. Damasio, Jr. | Executive |
| Gregory G. Freitag | Director |
| R Wayne Fritzsche | Director |
| R. Wayne Fritzsche | Director |
| Alan I. Goldberg | Director |
| Nathan P. Lawrence | Executive |
| Alexander Lazarev | Executive |
| Vito J. Mangiardi | Director |
| Conrad F. Mir | Executive |
| J Donald Payne | Director |
| J. Donald Payne | Director |
| Jeffrey N. Peterson | Director |
| Kevin A. Pollack | Director |
| Matthew B Potter | Executive |
| Alan D. Rosenson | Director |
| Calvin A. Saravis | Director |
| Richard T. Schumacher | Director, Executive |
| Richard P. Thomley | Executive |
| Edmund Y. Ting | Executive |
| Michael S. Urdea | Director |
| P Thomas Vogel | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
14 Norfolk Avenue
South Easton, MA, 02375
South Easton, MA, 02375